Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
Recruiting now Phase 2 NCT03997643
Run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · for 18 and older · All sexes
What this study is about
The goal of this randomized treatment study is to formally compare quality of life in patients with at least one pN0 hemi-neck after resection of a squamous cell carcinoma of the oral cavity treated with a primary radiation therapy versus a secondary targeted radiation therapy approach, to provide a high level of evidence to guide the selection of treatment options.
Who can join (things the study team will check)
✅ You may be able to join if…
- Willing to provide informed consent
- ECOG performance status 0-2
- Histologically confirmed, resected oral cavity squamous cell carcinoma with at least ipsilateral selective neck disection
- Patient has pathological features that are indications for PORT: positive or close (≤ 3 mm) margin, presence of LVI or PNU, pT3 or pT4 disease, positive lymph nodes, and PORT is recommended by treating physician
- Pathologically lympth node negative in at least one dissected hemi-neck with at least 10 nodes recovered in each pN0 hemi-neck
🚫 You may not be able to join if…
- Serious medical comorbidities or other contraindications to radiotherapy
- Prior history of head and neck cancer within 5 years
- Any other active invasive malignancy, except non-melanotic skin cancers
- Prior head and neck radiation at any time
- Prior oncologic head and neck surgery in the oral cavity or neck
- Metastatic disease
- Locoregional disease recurrence identified following surgical resection but prior to the start of radiotherapy
- Inability to attend full course of radio therapy or follow-up visits
- Unable or unwilling to complete QoL questionnaires
- Pregnant or lactating women
Where this trial is running
- Miami Cancer Institute, Miami, Florida, United States
- London Regional Cancer Program, London, Ontario, Canada
- CHUM, Montreal, Quebec, Canada
- Cork University Hospital, Wilton, County Cork, Ireland
- University Hospital Galway, Newcastle Road, Galway, County Galway, Ireland
- St. Luke's Radiation Oncology Network, Rathgar, Dublin, Ireland
- Beaumont St. Luke's Centre, Dublin, Leinster, Ireland
- Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.
Beacon is an information tool, not medical advice. Whether a trial is right for you is a decision for you, your doctor, and the study team. Trial details come from the official registry, ClinicalTrials.gov, and may change — always confirm with the study team. Beacon collects no data about you: this page has no cookies, no accounts, and no tracking.